NICE stats on decade of appraisals reveal 80% positive rate
This article was originally published in Clinica
Executive Summary
The UK’s National Institute for Health and Clinical Excellence (NICE) has published statistics related to its 367 technology appraisal recommendations, dating back to March 2000. Up to 30 June 2010, it issued 367 decisions, of which 245 (67%) were “recommended”, 61 (16%) resulted in an “optimised” decision; 22 (6%) were approved for research only; and 40 (11%) were not recommended. A further 11 appraisals were either withdrawn or could not be made due to non-submission of evidence. NICE has published the full table of 378 technology appraisals – it is available from the NICE website at: http://tinyurl.com/349f757/
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.